Q317 Market Recap Biosurgery Hemostats & Sealants: Supply Chain Disruptions
By Doug Devens, Senior Analyst Biosurgery
Surprisingly, the US market for Hemostats and Sealants was down vs Q217 and YoY, an anomaly from historic growth rates, primarily due to supply chain disruptions and softness in the thrombin hemostat segment.